Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biopharmadive.com/news/agios-royalty-pharma-vorasidenib-servier-brain-cancer-drug-deal/717198/#:~:text=Agios%20Pharmaceuticals%20has%20agreed%20to,win%20approval%20from%20U.S.%20regulators.
https://www.biopharmadive.com/news/cytokinetics-royalty-aficamten-omecamtiv-mecarbil-funding/716972/
https://www.globenewswire.com/news-release/2024/05/22/2886826/35409/en/Cytokinetics-and-Royalty-Pharma-Announce-Expanded-Strategic-Funding-Collaboration-Totaling-Up-to-575-Million-to-Support-Commercial-Launch-of-Aficamten-and-to-Advance-R-D-Pipeline.html
https://www.biopharmadive.com/news/sanofi-royalty-pharma-frexalimab-multiple-sclerosis-drug-deal/715657/
https://www.royaltypharma.com/news/royalty-pharma-announces-dividend-increase-2024/
https://www.royaltypharma.com/news/royalty-pharma-highlights-accomplishments-at-42nd-annual-j-p-morgan-healthcare-conference/
https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-evrysdi-royalty-agreement-with-royalty-pharma-for-up-to-1-5-billion-301961677.html
https://www.royaltypharma.com/news-releases/news-release-details/royalty-pharma-declares-fourth-quarter-2023-dividend
https://www.royaltypharma.com/news-releases/news-release-details/royalty-pharma-announce-third-quarter-2023-financial-results